Stay updated on Combination Dato-DXd Clinical Trial
Sign up to get notified when there's something new on the Combination Dato-DXd Clinical Trial page.
Latest updates to the Combination Dato-DXd Clinical Trial page
- Check28 days agoChange DetectedThe website has updated to version v2.14.0, adding a 'Contact: Principal Investigator' section and a new 'Type of intervention' feature, while removing the previous version's 'type of intervention' and reverting to an earlier revision.SummaryDifference11%
- Check50 days agoChange DetectedThe study has increased from 236 to 237 locations, with the latest revision updated to v2.13.3.SummaryDifference0.4%
- Check57 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference1.0%
- Check64 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' section and replaced it with a definitive 'Last Update Posted' section.SummaryDifference0.0%
- Check71 days agoChange DetectedTwo new studies have been added, one in Avignon, France, and another in Craiova, Romania, both currently recruiting participants.SummaryDifference2%
- Check79 days agoChange DetectedA new study has been added to assess the efficacy and safety of datopotamab deruxtecan in combination with pembrolizumab for advanced non-small cell lung cancer, with a focus on participants without actionable genomic alterations and high PD-L1 expression, while previous details about a similar study have been removed.SummaryDifference17%
Stay in the know with updates to Combination Dato-DXd Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Dato-DXd Clinical Trial page.